ABVC BioPharma's total assets for Q1 2025 were $14.88M, an increase of 97.29% from the previous quarter. ABVC total liabilities were $6.92M for the fiscal quarter, a 1.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.